Introduction
Sweat glands in the eyelid are classified as being either apocrine or eccrine in origin. Histopathologically, the apocrine features are manifested by deeply eosinophilic, columnar-to-cuboidal epithelium with basal nuclei and apical cytoplasmic snouts of decapitation secretion. Water-producing cysts lined by low, cuboidal, or flattened epithelium are classified as eccrine. The former tends to be much more common in the eyelids than their eccrine counterparts [1] . These apocrine glands were initially reported by -and named after the Dutch ophthalmologist -Jacob Moll , and Moll gland neoplasms are still considered to be clinically and pathologically a diagnostic challenge. A tubular apocrine adenoma (TAA) or tubular papillary adenoma (TPA) with apocrine dif-DOI: 10 .1159/000485426 ferentiation describes a rare and benign sweat gland tumor, most commonly to be found as a nodular solitary lesion on the scalp and first described by Landry and Winkelmann in 1972 [2] . It is described to contribute to a common spectrum of different apocrine neoplasms with distinct architectural characteristics. In this context, we report a TPA with apocrine differentiation found in an ectopic location of the conjunctival tarsal side of the upper eyelid.
Case Report
A 38-year-old woman presented with a 12-month history of an upper eyelid lesion in the middle of her left eye (Fig. 1a) . There was no previous ophthalmic history of the left eye; however, she had undergone strabismus surgery on the right, divergent, amblyopic eye at the age of 3 years. She denied any pain or rapidly expanding growth of the lesion in the given period. A hard, solid mass could be felt during palpation of the skin. When everting the eyelid, we found a well-circumscribed, solid, yellow mass that seemed to be located posterior to the tarsus, covered by conjunctiva (Fig. 1b) . Further ocular and orbital examination was unremarkable. The clinician's preoperative impression was that the lesion represented a tarsal plate cyst or an atypical chalazion without local redness due to inflammation. Whilst performing the excision, the tumor was found to be located entirely at the conjunctival side of the tarsus.
The eyelid was everted, and the lesion was excised en bloc together with the posterior side of the tarsus, leaving the bare tarsal plate. At the end of the surgery, this resulted in an intact eyelid margin of 3 mm. The wound was left to heal without sutures, with the application of dexamethason-tobramycin ointment for 10 days and a temporary eye pad. The solid tumor was conserved in toto in 10% buffered formalin and processed to paraffin sections. Fourmm-thick sections were cut and stained with hematoxylin and eosin (H&E) or periodic acid-Schiff (PAS).
Histopathological examination revealed an eyelid biopsy with part of the fibrous tarsal plate included. On the conjunctival side, a sessile, flattened, papillary tumor was found consisting of multiple interconnecting tubules in a thin fibrous stroma. The tumor's origin was defined at the conjunctival posterior side of the tarsus without invasion through the fibrous plate into the anterior lamella (Fig. 2a) . The tubules were all lined with a continuous bilayer epithelium of large columnar cells on the luminal side and smaller cuboidal or flattened cells on the basal side. The luminal cells showed a homogeneous, eosinophilic cytoplasm and PASpositive decapitation snouts on the PAS and H&E staining ( Fig. 2a-d) .
All nuclei were bland, round to oval, rarely with a small nucleolus and without any signs of atypia or pleiomorphism. No mitoses could be detected. The underlying stroma contained few small vessels and some lymphocytes but very few plasma cells. Immunostaining with cytokeratin 7 (Fig. 3) and epithelial membrane antigen was positive in the 2 layers of the tubules. Alpha-smooth muscle actin and androgen receptor were negative. CD138 showed only very few plasma cells in the stroma. Ki-67 was completely negative in the epithelial layers. Alcian blue staining was not performed.
Discussion
In this report, we describe a very rare benign eyelid TAA at an ectopic location. Even though multiple apocrine glands (or glands of Moll) are present in the eyelid, very few benign tumors with apocrine origin have been published at this location, besides hidrocystomas which are found along the eyelid margin and canthi. Following the WHO classification of apocrine tumors, the terms apocrine adenoma, tubular adenoma, tubulopapillary hidradenoma, and papillary tubular adenoma are synonyms [3] .
The TPA with apocrine differentiation (also called tubular apocrine adenoma [TAA]) is described as part of a common spectrum of 3 apocrine neoplasms. TPA with apocrine differentiation, syringocystadenoma papilliferum (SCAP), and apocrine gland cyst (AGC, also called apocrine hidrocystoma or apocrine cystadenoma) are reported to represent one spectrum with distinct architectural characteristics [4] . This idea has been supported by cases being published with either a varying degree of or simultaneous presence of these different entities in 1 lesion, which was initially described by Toribio et al. [5] in 1987 [6] . SCAP is composed of cysts and consists of a double layer of epithelial cells. The stroma often shows rich infiltration of inflammatory plasma cells, which is rarely detected in TPA and AGC. AGC has unilocular or multilocular cysts. TPA has been described as a nodular mass composed of multiple tubules outlined by a dual layer of epithelium with an apocrine type or decapitation secretion within the luminal cell layer. TPA differs in architecture from SCAP by (a) the lack of papillary projections, (b) no cystic invaginations extending down from the epidermis, and (c) the absence of inflammatory plasma cells [4] .
The apocrine origin of this lesion was proven by histopathological features and immunohistochemistry. The cardinal feature of TPA with apocrine differentiation in- cludes having a double layer of inner columnar and outer cuboidal cells and the presence of apical decapitation secretion in the inner columnar cells rather than forming simple secretory units with tubules, which is the case with their eccrine counterpart [7] . In the surrounding stroma consisting of collagen and fibroblast, very little plasma cell infiltration was present, detected with CD138 antibody staining. Malignancy was excluded due to a normal organization in structure and the absence of mitotic figures and atypia and no elevated Ki-67 staining.
Of the 2 types of sweat glands in the eyelids, only the apocrine glands of Moll are described as exclusively localized at or near the eyelid margin and canthi. Eccrine sweat glands, however, are not found at the eyelid margin but are found several millimeters from the lid margin in pretarsal and preseptal skin [1, 8] . In our patient, the location on the conjunctival tarsal side of the upper eyelid is rather unusual for its apocrine origin and would not raise obvious clinical suspicion, even though apocrine glands are found in the near proximity of the margin.
A TAA typically presents in the scalp region but has also been reported on the eyelid in previous cases [9] [10] [11] [12] . However, these reports described a TAA with an intradermal location on the eyelid, whereas the specimen in our case has its origin at the posterior conjunctival border of the tarsus. Hence, to our knowledge, our case could be considered as the first report of an ectopic TPA with apocrine differentiation in the eyelid.
When considering the differential diagnosis in our patient, the initial assessment of a solid lesion at the midtarsus with a yellow color on eversion of the eyelid would not raise suspicion for a TAA. Instead, one could strongly suspect a more common, intratarsal, keratinous cyst of the eyelid, due to its clinical appearance, the fixation of the lesion onto the tarsus, and the subconjunctival location [13] .
In conclusion, a TPA with apocrine differentiation on the eyelid is a rare and diagnostically challenging benign entity. This case is, to our knowledge, the first report in the English literature of an ectopic presentation in the eyelid and demonstrates that the appearance and location could be misleading in diagnosing this benign apocrine sweat gland tumor. We, therefore, strongly recommend relying on histopathological analysis, to demonstrate characteristic features such as apical decapitation snouts, the limited presence of plasma cells, and immunohistochemical staining as a conclusive guidance. Furthermore, a complete local excision is required to prevent recurrence.
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